Specialty Pharmacy

Researchers find biological evidence of repaired myelin.

Kick and kill strategy uses vaccine to stimulate immune system.

Abbott's new blood glucose meter is now widely available OTC without insurance co-pays.

Treatment will be available for clinical trials in patients with certain types of leukemia and non-Hodgkin lymphomas later this year.

Combination of nintedanib with docetaxel primarily depends on whether patients already had brain metastases.

UnitedHealth Group's Dr. Richard Migliori to speak at upcoming conference.

States with expanded Medicaid saw 25% more prescriptions filled last year.

Supplements containing creatine or androstenedione significantly increase disease risk.

A pharmacist who posted derogatory comments about a customer on social media is now being investigated by the National Health Service.

Co-administration of amiodarone with simeprevir and sofosbuvir combination is not recommended.

The American Academy of HIV Medicine has certified thousands of providers with specialist or expert designations.

The FDA today approved Sandoz's glatiramer acetate (Glatopa), a once-daily injection indicated for relapsing forms of multiple sclerosis.

US Marshals have seized $1.5 million worth of unapproved prescription drugs from Stratus Pharmaceuticals at the request of the FDA and the US attorney for the Southern District of Florida.

The FDA is considering approval for a liquid bendamustine hydrochloride rapid infusion product.

A record 4.3 billion prescriptions were filled in the United States last year.

Treatment found to lower blood sugar levels in obese mice.

Treatment dramatically reduces viral load in blood.

Low temperature plasmas found to induce high levels of DNA damage.

FDA warns of potential issues from diabetes drugs Onglyza, Kombiglyze, and Nesina.

When reporting diet and exercise, patients may feel pressured to say what they think clinicians want to hear.

Inhibiting a previously undruggable protein holds promise for treatment of numerous types of cancer.

High cost of new drugs make treating even the sickest inmates impractical.

Longer telomeres gives cancer cells a survival advantage.

Gilead Sciences is seeking FDA approval for emtricitabine/tenofovir alafenamide.

Kjel Jonhson, PharmD, Vice President of Global Oncology for IMS Health, discusses innovative new therapies for the treatment of cancer.

CCZ impairs the ability of the virus to enter human liver cells.

Ibrutinib found to control Waldenstrom's Macroglobulinemia in 95% of patients.

Analysis of cancer-causing mutations in the BRCA1 or BRCA2 genes may lead to more effective treatments.